XML 109 R21.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Stockholders' Equity | 12 Months Ended
--- | ---
Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Stockholders' Equity | 13. Stockholders’ Equity 2008 Stock Incentive Plan—During 2008, our stockholders approved an Incentive Stock Plan (the “2008 Plan”). The number of shares of our common stock available for issuance under the 2008 Plan was 1,000,000 shares, subject to adjustment. Under the 2008 Plan, awards may be made to any employee, officer or director of the Company and its affiliated companies. An award may also be granted to any consultant, agent, advisor or independent contractor for bona fide services rendered to the Company or any affiliate (as defined in the 2008 Plan), subject to certain conditions. The 2008 Plan is being administered by the compensation and stock option committee (the “Committee”) of our board of directors. Our board of directors or the Committee may amend the 2008 Plan, except that if any applicable statute, rule or regulation requires shareholder approval with respect to any amendment of the 2008 Plan, then to the extent so required, shareholder approval will be obtained. Shareholder approval will also be obtained for any amendment that would increase the number of shares stated as available for issuance under the 2008 Plan. Unless sooner terminated by our board of directors, the 2008 Plan expires on June 5, 2018. The following may be granted by the Committee under the 2008 Plan: Stock Options—The Committee may grant either incentive stock options or non-qualified stock options. The Committee sets option exercise prices and terms, except that the exercise price of a stock option may be no less than 100% of the fair market value, as defined in the 2008 Plan, of the shares on the date of grant. At the time of grant, the Committee will have sole discretion in determining when stock options are exercisable and when they expire, except that the term of a stock option cannot exceed 10 years. Stock Appreciation Rights (“SARs”)—The Committee may grant SARs as a right in tandem with the number of shares underlying stock options granted under the 2008 Plan or on a stand-alone basis. SARs are the right to receive payment per share of the SAR exercised in stock or in cash equal to the excess of the share’s fair market value, as defined in the 2008 Plan, on the date of exercise over its fair market value on the date the SAR was granted. Exercise of a SAR issued in tandem with stock options will result in the reduction of the number of shares underlying the related stock option to the extent of the SAR exercise. Stock Awards, Restricted Stock, Restricted Stock Units, and Other Awards—The Committee may grant awards of restricted stock, restricted stock units, and other stock and cash-based awards, which may include the payment of stock in lieu of cash (including cash payable under other incentive or bonus programs) or the payment of cash (which may or may not be based on the price of our common stock). Outside Directors Stock Option Plan—In addition to the 2008 Plan discussed above, we have an Outside Directors Stock Option Plan (the “Outside Director Plan”). The Outside Director Plan authorizes the grant of non-qualified stock options to each member of our board of directors who is not an officer or employee of LSB or its subsidiaries. The Outside Director Plan also provides that each outside director may elect to receive all or any portion of his or her director fee for services rendered as a director of LSB in shares of LSB’s common stock, provided that the outside director elects to receive shares in payment of his or her director fee each calendar quarter. The maximum number of shares that may be issued, or for which options may be granted, under the Outside Director Plan is 400,000 of which 280,000 were available for issuance, or grant of options, at December 31, 2013. Stock-Based Compensation—During 2013 and 2012, the Committee did not grant any awards under the 2008 Plan. During 2011, the Committee approved the grants under the 2008 Plan of 249,000 shares of qualified stock options (the “2011 Qualified Options”) to certain employees and our board of directors (with the recipient abstaining) approved the grant of 5,000 shares of non-qualified stock options (“2011 Non-Qualified Options”) to one of our outside directors. The exercise price of the 2011 Qualified and Non-Qualified Options was equal to the market value of our common stock at the date of grant. The 2011 Qualified and Non-Qualified Options vest at the end of each one-year period at the rate of 16.5% per year for the first five years and the remaining unvested options will vest at the end of the sixth year. Pursuant to the terms of the 2011 Non-Qualified Options, if a termination event occurs, as defined, the non-vested 2011 Non-Qualified Options will become fully vested and exercisable for a period of one year from the date of the termination event. Excluding the non-qualified stock options relating to a termination event, the 2011 Qualified and Non-Qualified Options expire in 2021. The fair value for the 2011 Qualified and Non-Qualified Options was estimated, using an option pricing model, as of the date of the grant, which date was also the service inception date. The fair value for the 2011 Qualified and Non-Qualified Options was estimated using a Black-Scholes-Merton option pricing model with the following assumptions:
| • |  | risk-free interest rate based on an U.S. Treasury zero-coupon issue with a term approximating the estimated expected life as of the grant date;
| • |  | a dividend yield based on historical data;
| • |  | volatility factors of the expected market price of our common stock based on historical volatility of our common stock primarily over approximately six years from the date of grant; and
| • |  | a weighted-average expected life of the options based on the historical exercise behavior of these employees and outside director, if applicable.
The following table summarizes information about these granted stock options:
|  | 2013 |  |  | 2012 |  |  | 2011 |
Weighted-average risk-free interest rate |  |  | N/A |  |  |  | N/A |  |  |  | 1.21 | %
Dividend yield |  |  | N/A |  |  |  | N/A |  |  |  | — |
Weighted-average expected volatility |  |  | N/A |  |  |  | N/A |  |  |  | 48.59 | %
Total weighted-average expected forfeiture rate |  |  | N/A |  |  |  | N/A |  |  |  | 2.97 | %
Weighted-average expected life (years) |  |  | N/A |  |  |  | N/A |  |  |  | 5.90 |
Total weighted-average remaining vesting period in years (1) |  |  | 2.45 |  |  |  | 3.38 |  |  |  | 4.30 |
Total fair value of options granted |  |  | N/A |  |  |  | N/A |  |  | $ | 4,064,000 |
Stock-based compensation expense—Cost of sales (1) |  | $ | 227,000 |  |  | $ | 278,000 |  |  | $ | 60,000 |
Stock-based compensation expense—SG&A (1) |  | $ | 1,315,000 |  |  | $ | 1,374,000 |  |  | $ | 1,039,000 |
Income tax benefit (1) |  | $ | (601,000 | ) |  | $ | (603,000 | ) |  | $ | (390,000 | )
(1) | Information relates to stock options granted since 2006.
At December 31, 2013, the total stock-based compensation expense not yet recognized is $4,405,000 relating to non-vested stock options, which we will be amortizing (subject to adjustments for forfeitures) through the respective remaining vesting periods. Qualified Stock Option Plans—At December 31, 2013, we have options outstanding under a 1998 Stock Option Plan (“1998 Plan”) and the 2008 Plan as discussed above. The 1998 Plan has expired, and accordingly, no additional options may be granted from the 1998 Plan. Options granted prior to the expiration of this plan continue to remain valid thereafter in accordance with their terms. The exercise price of the outstanding options granted under the 1998 and 2008 Plans was equal to the market value of our common stock at the date of grant. The following information relates to our qualified stock option plans:
|  | December 31, 2013 |
|  | 2008 Plan |  |  | 1998 Plan |
Maximum number of securities for issuance |  |  | 1,000,000 |  |  |  | N/A |
Number of awards available to be granted |  |  | 372,130 |  |  |  | N/A |
Number of qualified options outstanding |  |  | 402,405 |  |  |  | 11,000 |
Number of qualified options exercisable |  |  | 190,670 |  |  |  | 11,000 |
|  | 2013 |
|  | Shares |  |  | Weighted- Average Exercise Price |
Outstanding at beginning of year |  |  | 478,915 |  |  | $ | 22.28 |
Granted |  |  | — |  |  |  | N/A |
Exercised |  |  | (43,285 | ) |  | $ | 10.16 |
Cancelled, forfeited or expired |  |  | (22,225 | ) |  | $ | 32.21 |
Outstanding at end of year |  |  | 413,405 |  |  | $ | 23.01 |
Exercisable at end of year |  |  | 201,670 |  |  | $ | 18.39 |
|  | 2013 |  |  | 2012 |  |  | 2011 |
Weighted-average fair value per option granted during year |  |  | N/A |  |  |  | N/A |  |  | $ | 16.00 |
Total intrinsic value of options exercised during the year |  | $ | 1,149,000 |  |  | $ | 895,000 |  |  | $ | 3,294,000 |
Total fair value of options vested during the year |  | $ | 828,000 |  |  | $ | 861,000 |  |  | $ | 208,000 |
The following table summarizes information about qualified stock options outstanding and exercisable at December 31, 2013:
|  | Stock Options Outstanding |
Exercise Prices |  | Shares Outstanding |  |  | Weighted- Average Remaining Contractual Life in Years |  |  | Weighted- Average Exercise Price |  |  | Intrinsic Value of Shares Outstanding |
$ 5.10 |  |  | 11,000 |  |  |  | 1.92 |  |  | $ | 5.10 |  |  | $ | 395,000 |
$ 7.86 – $8.17 |  |  | 41,755 |  |  |  | 4.92 |  |  | $ | 7.87 |  |  |  | 1,384,000 |
$ 9.69 – $9.97 |  |  | 132,650 |  |  |  | 4.83 |  |  | $ | 9.69 |  |  |  | 4,156,000 |
$29.99 – $34.50 |  |  | 228,000 |  |  |  | 7.90 |  |  | $ | 34.40 |  |  |  | 1,509,000 |
$5.10 – $34.50 |  |  | 413,405 |  |  |  | 6.46 |  |  | $ | 23.01 |  |  | $ | 7,444,000 |
|  | Stock Options Exercisable |
Exercise Prices |  | Shares Outstanding |  |  | Weighted- Average Remaining Contractual Life in Years |  |  | Weighted- Average Exercise Price |  |  | Intrinsic Value of Shares Outstanding |
$ 5.10 |  |  | 11,000 |  |  |  | 1.92 |  |  | $ | 5.10 |  |  | $ | 395,000 |
$ 7.86 – $8.17 |  |  | 30,030 |  |  |  | 4.92 |  |  | $ | 7.86 |  |  |  | 996,000 |
$ 9.69 – $9.97 |  |  | 85,400 |  |  |  | 4.83 |  |  | $ | 9.69 |  |  |  | 2,675,000 |
$29.99 – $34.50 |  |  | 75,240 |  |  |  | 7.90 |  |  | $ | 34.40 |  |  |  | 498,000 |
$5.10 – $34.50 |  |  | 201,670 |  |  |  | 5.83 |  |  | $ | 18.39 |  |  | $ | 4,564,000 |
Non-Qualified Stock Option Plans—In 2006, our stockholders approved the grants of non-qualified stock options to our outside directors and certain key employees, including the grant of 450,000 shares of non-qualified stock options (the “2006 Options”) to certain Climate Control Business employees. The exercise price of the 2006 Options is $8.01 per share. At December 31, 2013, there were 31,225 options outstanding related to the 2008 Plan, of which 22,625 are exercisable, and no options outstanding related to the Outside Director Plan. The following information relates to our non-qualified stock option plans:
|  | 2013 |
|  | Shares |  |  | Weighted- Average Exercise Price |
Outstanding at beginning of year |  |  | 258,050 |  |  | $ | 8.50 |
Granted |  |  | — |  |  |  | N/A |
Exercised |  |  | (71,825 | ) |  | $ | 8.00 |
Surrendered, forfeited or expired |  |  | — |  |  |  | N/A |
Outstanding at end of year |  |  | 186,225 |  |  | $ | 8.70 |
Exercisable at end of year |  |  | 42,625 |  |  | $ | 8.96 |
|  | 2013 |  |  | 2012 |  |  | 2011 |
Weighted-average fair value per option granted during year |  |  | N/A |  |  |  | N/A |  |  | $ | 16.25 |
Total intrinsic value of options exercised during the year |  | $ | 1,821,000 |  |  | $ | 1,574,000 |  |  | $ | 2,110,000 |
Total fair value of options vested during the year |  | $ | 737,000 |  |  | $ | 731,000 |  |  | $ | 730,000 |
The following tables summarize information about non-qualified stock options outstanding and exercisable at December 31, 2013:
|  | Stock Options Outstanding |
Exercise Prices |  | Shares Outstanding |  |  | Weighted- Average Remaining Contractual Life in Years |  |  | Weighted- Average Exercise Price |  |  | Intrinsic Value of Shares Outstanding |
$ 7.86 |  |  | 26,225 |  |  |  | 4.33 |  |  | $ | 7.86 |  |  | $ | 870,000 |
$ 8.01 |  |  | 155,000 |  |  |  | 2.75 |  |  | $ | 8.01 |  |  |  | 5,116,000 |
$34.50 |  |  | 5,000 |  |  |  | 7.92 |  |  | $ | 34.50 |  |  |  | 33,000 |
$7.86 – $34.50 |  |  | 186,225 |  |  |  | 3.11 |  |  | $ | 8.70 |  |  | $ | 6,019,000 |
|  | Stock Options Exercisable |
Exercise Prices |  | Shares Outstanding |  |  | Weighted- Average Remaining Contractual Life in Years |  |  | Weighted- Average Exercise Price |  |  | Intrinsic Value of Shares Outstanding |
$ 7.86 |  |  | 20,975 |  |  |  | 4.33 |  |  | $ | 7.86 |  |  | $ | 695,000 |
$ 8.01 |  |  | 20,000 |  |  |  | 2.75 |  |  | $ | 8.01 |  |  |  | 660,000 |
$34.50 |  |  | 1,650 |  |  |  | 7.92 |  |  | $ | 34.50 |  |  |  | 11,000 |
$7.86 – $34.50 |  |  | 42,625 |  |  |  | 3.73 |  |  | $ | 8.96 |  |  | $ | 1,366,000 |
Debt Conversion into Common Stock—During 2011, the remaining $26.9 million of the 5.5% convertible debentures (“2007 Debentures”) were converted into 979,160 shares of LSB common stock including the portion of 2007 debentures held by Jack E. Golsen (“Golsen”), our chairman of the board and chief executive officer (“CEO”), members of his immediate family, entities owned by them and trusts for which they possess voting or dispositive power as trustee (collectively, the “Golsen Group”) as discussed in Note 19-Related Party Transactions. In addition for financial reporting purposes, one of the conversion transactions with an unrelated third party was considered an induced conversion. Preferred Share Rights Plan—On January 5, 2009, a renewed shareholder rights plan became effective upon the expiration of our previous shareholder rights plan. The rights plan will impact a potential acquirer unless the acquirer negotiates with our board of directors and the board of directors approves the transaction. Pursuant to the renewed plan, one preferred share purchase right (a “Right”) is attached to each currently outstanding or subsequently issued share of our common stock. Prior to becoming exercisable, the Rights trade together with our common stock. In general, if a person or group acquires or announces a tender or exchange offer for 15% or more of our common stock (except for the Golsen Group and certain other limited excluded persons), then the Rights become exercisable. Each Right entitles the holder (other than the person or group that triggers the Rights being exercisable) to purchase from us one one-hundredth of a share of Series 4 Junior Participating Preferred Stock, no par value (the “Preferred Stock”), at an exercise price of $47.75 per one one-hundredth of a share, subject to adjustment. If a person or group acquires 15% or more of our common stock, each Right will entitle the holder (other than the person or group that triggered the Rights being exercisable) to purchase shares of our common stock (or, in certain circumstances, cash or other securities) having a market value of twice the exercise price of a Right at such time. Under certain circumstances, each Right will entitle the holder (other than the person or group that triggered the Rights being exercisable) to purchase the common stock of the acquirer having a market value of twice the exercise price of a Right at such time. In addition, under certain circumstances, our board of directors may exchange each Right (other than those held by the acquirer) for one share of our common stock, subject to adjustment. Our board of directors may redeem the Rights at a price of $0.01 per Right generally at any time before 10 days after the Rights become exercisable. Our board of directors may exchange all or part of the Rights (except to the person or group that triggered the Rights being exercisable) for our common stock at an exchange ratio of one common share per Right until the person triggering the Right becomes the beneficial owner of 50% or more of our common stock. Other—As of December 31, 2013, we have reserved 1.5 million shares of common stock issuable upon potential conversion of preferred stocks and stock options pursuant to their respective terms.

X
- Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. + References No definition available. + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration